Evaluating the efficacy and safety of two doses of the polyclonal anti-tumor necrosis factor-α fragment antibody AZD9773 in adult patients with severe sepsis and/or septic shock: randomized, double-blind, placebo-controlled phase IIb study*. (Q42236968)
Jump to navigation
Jump to search
scientific article published on March 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Evaluating the efficacy and safety of two doses of the polyclonal anti-tumor necrosis factor-α fragment antibody AZD9773 in adult patients with severe sepsis and/or septic shock: randomized, double-blind, placebo-controlled phase IIb study*. |
scientific article published on March 2014 |
Statements
Evaluating the efficacy and safety of two doses of the polyclonal anti-tumor necrosis factor-α fragment antibody AZD9773 in adult patients with severe sepsis and/or septic shock: randomized, double-blind, placebo-controlled phase IIb study* (English)
Gordon R Bernard
R Phillip Dellinger
James A Russell
Steven P Larosa
Pierre-Francois Laterre
Mitchell M Levy
Wayne Dankner
Nicola Schmitt
Xavier Wittebole